BREAKING: WHO Suspends Trial Of Hydroxychloroquine As COVID-19 Treatment Over Safety Concerns
Posted by E.L.E.X on May 26 2020 under News
The World Health Organisation has suspended testing malaria drug, Hydroxychloroquine, in COVID-19 patients due to safety concerns.
WHO Director-General, Tedros Adhanom Ghebreyesus, in a virtual press conference on Monday, said the decision came after the publication last week of a study indicating that using the drug on COVID-19 patients could increase their likelihood of dying.
Hydroxycholoroquine has been touted by United States President, Donald Trump, and others as a possible treatment for the disease.
Trump had said he was taking the drug to help prevent infection.
“The executive group has implemented a temporary pause of the Hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” Ghebreyesus said.
Tweet
YOU MAY ALSO LIKE
Comments
Add Comment
All fields are required!
Are you interested in Advert placement | Promoting your Music or Video | Other Enquiries? We are always available to get that done for you without breaking a sweat. Send us a mail @ elextechnologies4@gmail.com | Call us @ 08132021949 | Message us via whatsapp @ 08132021949
